Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 6 | 2022 | 730 | 0.590 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2022 | 549 | 0.590 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 146 | 0.380 |
Why?
|
| Nutritional Status | 2 | 2003 | 83 | 0.260 |
Why?
|
| Colitis, Ulcerative | 3 | 2022 | 711 | 0.250 |
Why?
|
| Child | 14 | 2022 | 6928 | 0.240 |
Why?
|
| Growth | 1 | 2003 | 43 | 0.230 |
Why?
|
| Child Nutrition Disorders | 1 | 2003 | 12 | 0.230 |
Why?
|
| Health Services | 1 | 2003 | 55 | 0.220 |
Why?
|
| Gastroenterology | 1 | 2003 | 134 | 0.190 |
Why?
|
| Growth Disorders | 1 | 2020 | 63 | 0.190 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 1801 | 0.190 |
Why?
|
| Body Height | 1 | 2020 | 99 | 0.190 |
Why?
|
| Eosinophilia | 1 | 2001 | 84 | 0.190 |
Why?
|
| Abdominal Pain | 1 | 2001 | 137 | 0.180 |
Why?
|
| Child Development | 1 | 2021 | 163 | 0.170 |
Why?
|
| Sex Characteristics | 1 | 2021 | 319 | 0.170 |
Why?
|
| Adolescent | 11 | 2021 | 8982 | 0.170 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 102 | 0.160 |
Why?
|
| Patient Care | 1 | 2019 | 100 | 0.160 |
Why?
|
| Child, Preschool | 6 | 2021 | 3613 | 0.160 |
Why?
|
| Immunologic Factors | 1 | 2019 | 170 | 0.160 |
Why?
|
| Phenobarbital | 1 | 1997 | 33 | 0.150 |
Why?
|
| Sex Factors | 1 | 2020 | 1054 | 0.150 |
Why?
|
| Adenoma, Liver Cell | 1 | 1996 | 2 | 0.150 |
Why?
|
| Bone Density | 1 | 1998 | 209 | 0.150 |
Why?
|
| Periodicity | 1 | 1997 | 119 | 0.140 |
Why?
|
| Hypnotics and Sedatives | 1 | 1997 | 125 | 0.140 |
Why?
|
| Milk Proteins | 1 | 2016 | 24 | 0.140 |
Why?
|
| Infant Formula | 1 | 2016 | 17 | 0.140 |
Why?
|
| Mass Screening | 1 | 2020 | 618 | 0.140 |
Why?
|
| Milk Hypersensitivity | 1 | 2016 | 10 | 0.140 |
Why?
|
| Celiac Disease | 1 | 2019 | 203 | 0.140 |
Why?
|
| Vomiting | 1 | 1997 | 193 | 0.130 |
Why?
|
| Problem Solving | 1 | 2015 | 54 | 0.130 |
Why?
|
| Gastritis | 1 | 2015 | 32 | 0.130 |
Why?
|
| Fever | 1 | 2015 | 125 | 0.130 |
Why?
|
| Medication Adherence | 1 | 2015 | 129 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2015 | 182 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 582 | 0.120 |
Why?
|
| Infant, Premature | 1 | 2016 | 290 | 0.120 |
Why?
|
| Chronic Disease | 3 | 2019 | 971 | 0.110 |
Why?
|
| Inflammation | 1 | 2019 | 920 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2015 | 229 | 0.110 |
Why?
|
| Blood Sedimentation | 1 | 2012 | 13 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 3 | 2019 | 1376 | 0.110 |
Why?
|
| Female | 13 | 2022 | 44534 | 0.110 |
Why?
|
| Menarche | 2 | 2022 | 24 | 0.100 |
Why?
|
| Thalidomide | 1 | 2012 | 54 | 0.100 |
Why?
|
| Fistula | 1 | 2012 | 42 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2012 | 339 | 0.100 |
Why?
|
| Prednisone | 1 | 2012 | 258 | 0.100 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2010 | 1 | 0.100 |
Why?
|
| Male | 12 | 2021 | 40967 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2271 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 736 | 0.090 |
Why?
|
| Humans | 18 | 2022 | 86645 | 0.090 |
Why?
|
| Intestines | 1 | 2012 | 411 | 0.080 |
Why?
|
| Colitis | 1 | 2010 | 239 | 0.080 |
Why?
|
| Quality of Life | 1 | 2015 | 1585 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1019 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 3640 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2021 | 4213 | 0.070 |
Why?
|
| Hospitalization | 1 | 2012 | 849 | 0.070 |
Why?
|
| Infant | 2 | 2016 | 3047 | 0.060 |
Why?
|
| Anthropometry | 1 | 2003 | 74 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2015 | 7993 | 0.060 |
Why?
|
| Biopsy | 2 | 2015 | 1163 | 0.050 |
Why?
|
| Thioguanine | 1 | 2001 | 17 | 0.050 |
Why?
|
| Mercaptopurine | 1 | 2001 | 53 | 0.050 |
Why?
|
| Age Determination by Skeleton | 1 | 2020 | 12 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2016 | 2379 | 0.050 |
Why?
|
| Puberty, Delayed | 1 | 2020 | 19 | 0.050 |
Why?
|
| Infliximab | 2 | 2012 | 151 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2001 | 236 | 0.050 |
Why?
|
| Jews | 1 | 2019 | 42 | 0.040 |
Why?
|
| Butyrophilins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2019 | 16 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2019 | 80 | 0.040 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 52 | 0.040 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1998 | 12 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 310 | 0.040 |
Why?
|
| Glutens | 1 | 2019 | 76 | 0.040 |
Why?
|
| Radius | 1 | 1998 | 29 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 977 | 0.040 |
Why?
|
| Puberty | 1 | 1998 | 59 | 0.040 |
Why?
|
| Antigens | 1 | 2019 | 228 | 0.040 |
Why?
|
| Hormones | 1 | 1998 | 141 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 966 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 1997 | 40 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 615 | 0.040 |
Why?
|
| Reference Values | 1 | 1998 | 674 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 372 | 0.040 |
Why?
|
| Protein Hydrolysates | 1 | 2016 | 9 | 0.030 |
Why?
|
| Milk | 1 | 2016 | 53 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 2601 | 0.030 |
Why?
|
| Liver | 2 | 2001 | 1230 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2016 | 60 | 0.030 |
Why?
|
| Birth Weight | 1 | 2016 | 145 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2016 | 102 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 376 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1239 | 0.030 |
Why?
|
| Amino Acids | 1 | 2016 | 252 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2016 | 78 | 0.030 |
Why?
|
| Recurrence | 1 | 1997 | 1139 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2015 | 153 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 684 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 797 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2015 | 161 | 0.030 |
Why?
|
| Calcium | 1 | 1998 | 1156 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2016 | 8491 | 0.030 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2012 | 62 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1565 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 3680 | 0.030 |
Why?
|
| Adalimumab | 1 | 2012 | 80 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 85 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 213 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 746 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5417 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2501 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 5976 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1531 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 930 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 25648 | 0.010 |
Why?
|
| Leukopenia | 1 | 2001 | 65 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2001 | 220 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 370 | 0.010 |
Why?
|
| Azathioprine | 1 | 2001 | 125 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 26582 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2001 | 255 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 25028 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2001 | 678 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 1621 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 2232 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 11352 | 0.000 |
Why?
|